C oronary artery disease remains the leading cause of death in United States. 1 With significant advances in medical and reperfusion strategies, there have been marked improvements in both short-term and long-term outcomes among patients presenting with ST-segment-elevation myocardial infarction (STEMI). Improvement in clinical outcomes after STEMI depends greatly on the timely utilization of proven therapies with emphasis on the time to reperfusion. 2 Previously published data from 1999 to 2005 have demonstrated disparities in reperfusion times among patients with STEMI based on the time of presentation. [3] [4] [5] [6] Patients presenting during evening and nighttime, weekends, and national holidays (off-hour presentation) are less likely to achieve certain quality measures of STEMI care such as door-to-balloon (D2B) time ≤90 minutes, door-to-ECG time ≤10 minutes, and door-to-needle (D2N) time ≤30 minutes. [3] [4] [5] [6] [7] [8] [9] [10] 
on the time of presentation: during daytime (on-hours) versus nighttime and weekend/holiday presentation (off-hours).
Materials and Methods

Data Source and Methods
The ACTION Registry-GWTG is a voluntary registry that receives data on consecutive patients with acute myocardial infarction from hospitals throughout the United States. Trained data collection personnel perform data collection via individual chart review. Data quality is maintained through mechanisms including point-of-entry and quarterly data quality checks and query reconciliation. ACTION Registry-GWTG serves as the hospital data collection and evaluation mechanism for American Heart Association's Mission Lifeline program. The Duke Clinical Research Institute serves as the data analysis center and has an agreement to analyze the aggregate deidentified data for research purposes. Hospitals participating in the registry submit clinical information on the medical history, hospital care, and outcomes of consecutive patients hospitalized for acute myocardial infarction using an online, interactive case report form supplied by ACTION Registry-GWTG. Any STEMI system, hospital, and emergency medical service information that was not completed in ACTION Registry-GWTG could be supplied through the American Heart Association online survey tools, Vovici Corporation (Dulles, VA) or ROK Technologies (Charleston, SC). All participating institutions were required to comply with local regulatory and privacy guidelines and, if required, to secure institutional review board approval. Because data were used primarily at the local site for quality improvement, sites were granted a waiver of informed consent under the common rule. The overall GWTG program objective has been described previously. 12, 13 The National Cardiovascular Data Registry-Acute Coronary Treatment and Intervention Outcomes Network (NCDR-ACTION) database includes a variety of hospitals, including teaching and nonteaching, rural and urban, and large and small hospitals (from all regions of United States).
At the time of analysis, the ACTION Registry-GWTG database contained 232 012 patients with myocardial infarction between January 2007 and September 2010 from 538 hospitals. Patients were excluded from this analysis if they presented with non-ST-segmentelevation myocardial infarction (n=140 943), presented to centers that used the limited data collection form (n=3829), arrived to hospital in year 2006 (n=158), had missing arrival time (n=66), transferred in from outside hospitals (n=29 777), had the first evaluation outside the emergency department (n=2365), did not receive either primary percutaneous coronary intervention (PCI) or fibrinolytic therapy (n=11 512), had contraindications to both primary PCI and fibrinolytic therapy (n = 7), had stable, successful reperfusion for STEMI,
WHAT IS KNOWN
• ST-segment-elevation myocardial infarction is a leading cause of cardiovascular morbidity and mortality.Quality initiatives led by the American Heart Association and other organizations have led to early institution of reperfusion therapies (mainly percutaneous coronary intervention), thereby significantly improving cardiovascular outcomes.
WHAT THE STUDY ADDS
• Data from the current analysis indicate that majority of the patients with ST-segment-elevation myocardial infarction do receive timely reperfusion. However, certain gaps in ST-segment-elevation myocardial infarction care still exist, especially so in patients presenting to the hospital during evening/ night hours, weekends, and holidays, which may translate into slightly worse outcomes. • Concerted efforts to reduce such disparities will pave the way for improved quality of care and outcomes in ST-segment-elevation myocardial infarction. or completed infarction post-STEMI or other (n=113; Figure) Thus, the final cohort comprised 43 242 patients with STEMI, defined as having an initial ECG on arrival showing diagnostic ST-segment elevation or new left bundle branch block from 447 centers across the United States and who received either primary PCI (n=41 979; 97.1%) or fibrinolytic therapy (n=1098; 2.5%; Figure) Hospital arrival time (on-hours versus off-hours) was the primary basis for classification of the study cohort. On-hour arrival was defined as weekdays (Monday through Friday; 8 AM to 6 PM). Off-hour arrival was defined as weeknights (6 PM to 8 AM), weekends, and holidays. Holidays included New Year (December 31 and January 1), Christmas (December 24 and 25), Memorial, Independence, Labor, and Thanksgiving days (Wednesday 6 PM through following Monday 8 AM). Acute reperfusion therapies were analyzed among the reperfusion-eligible STEMI cohort. Primary outcomes of interest were as follows: aspirin use within 24 hours, door-to-ECG time ≤10 minutes, D2B ≤90 minutes, and D2N ≤30 minutes. D2N time was defined as the time from hospital arrival to initiation of fibrinolytic therapy;
D2B time was defined as the time from hospital arrival to first balloon inflation. The secondary outcome was in-hospital mortality. For the mortality analyses, transferred out (n=1672) patients were excluded. Among those undergoing primary PCI, mortality analyses were conducted with (n=4155) and without exclusion of nonsystem reason for delay in PCI. Nonsystem-related delay was secondary to patient-level factors, and system delay was related to hospital-level factors.
Statistical Analysis
For the descriptive analysis, patients' sociodemographic and medical history variables, baseline clinical characteristics, invasive procedures, quality of care measures, and in-hospital outcomes were compared among patients arriving during off-hours versus on-hours. Percentages and medians (25th and 75th percentiles) were reported to describe the distribution of the categorical and continuous variables, respectively. Categorical and continuous variables were compared using the χ 2 and the Wilcoxon rank-sum test, respectively. To evaluate the relationship between in-hospital mortality and on-duty and off-duty hours, logistic generalized estimating equation method with exchangeable working correlation matrix was used to account for within-hospital clustering because patients at the same hospital are more likely to have similar responses relative to patients at other hospitals (ie, within-center correlation for responses). 14 This method produces estimates similar to those from ordinary logistic regression, but variances are adjusted for the correlation of outcomes within a hospital. Variables included in the model were from a recently validated NCDR-ACTION in-hospital mortality model, and they are age, baseline serum creatinine, systolic blood pressure, baseline troponin elevation, heart failure or cardiogenic shock at presentation, heart rate, and prior peripheral arterial disease. 15 Odds ratios (95% confidence intervals) for in-hospital mortality by off-hours and onhours were presented, where the reference is on-hours. All analyses were performed using SAS software (version 9.2; SAS Institute, Cary, NC). All statistical analyses were conducted independently by the Duke Clinical Research Institute (Durham, NC). The authors had full access to and take full responsibility for the integrity of the data. All authors have read and agree to the article as written.
Table 1. Baseline Demographic, Clinical, and Presentation Characteristics of Patients With ST-Segment-Elevation Myocardial Infarction Based on Time of Presentation
Results
A total of 43 242 patients presenting with STEMI were analyzed, of which 27 270 (63%) presented during off-hours. Patients who presented off-hours were younger (median age, 59 versus 61 years). In general, the patient baseline and clinical presentation characteristics were similar between onhours and off-hours, except for recent/current smoking status. (Table 1) The use of recommended medications was high, regardless of the time of presentation. Aspirin use within the first 24 hours of admission (acute) was high during both on-hours (99.1%) and off-hours (98.9%). Use of unfractionated heparin anytime during hospitalization was greater during off-hours (76.3 versus 72.1%) than on-hours (Table 2) .
Median arrival to ECG time was 6 minutes in each group. In patients treated with primary PCI, median D2B was 16 minutes longer in patients presenting off-hours (72 versus 56 minutes). The proportion of patients achieving D2B time ≤90 minutes was less frequent in patients presenting off-hours (79.2% versus 87.8%). Median D2N times and proportion of patients with D2N time ≤30 minutes were similar, regardless of the time of presentation (Table 3) .
In-hospital all-cause mortality was 4.2% in both groups ( Table 4 ). The unadjusted mortality was similar during offhours versus on-hours in overall population and primary PCI subgroup (even after excluding nonsystem reason for delay in PCI; Table 4 ). The adjusted all-cause in-hospital mortality was higher during off-hours in the overall STEMI cohort (odds ratio, 1.13; 95% confidence interval, 1.02-1.26) and borderline significantly higher for primary PCI group (odds ratio, 1.12; 95% confidence interval, 1.00-1.25) but no longer statistically significantly higher in primary PCI group after excluding nonsystem reasons for delay in PCI (odds ratio, 1.10; 95% confidence interval, 0.95-1.27). Other in-hospital adverse outcomes were similar in both groups ( Table 5 ).
Discussion
In this large contemporary cohort study, from the ACTION Registry-GWTG database, involving 43 242 patients with STEMI, we found that achievement of major quality measures of STEMI care was high, regardless of the time of presentation. The D2B time was higher in patients presenting offhours, and the risk-adjusted in-hospital all-cause mortality was higher during off-hours for the overall population.
Historically, patients with STEMI presenting off-hours had higher D2B times compared with those during on-hours. 3, 16 A previous GWTG analysis (2000-2005; 62 814 patients) reported that only 31% of patients with STEMI presenting offhours achieved a D2B time ≤90 minutes, whereas the National Registry of Myocardial Infarction analysis (1999-2002; 68 439 patients) reported that 26% of the patients presenting off-hours achieved D2B time ≤90 minutes. 3, 16 Our analysis (2007) (2008) (2009) (2010) , however, demonstrated that ≈80% of patients achieved the target D2B time of ≤90 minutes. Significant improvements have occurred in D2B time during off-hours when comparing our recent analysis with those in the literature (median time of 72 minutes compared with 110 and 116 minutes from 2 large databases). 3, 16 The proportion of off-hour patients receiving primary PCI and achieving a D2B time of ≤90 minutes was 8.6% (absolute difference) lower than onhour patients. However, the absolute difference in the median D2B time was only 16 minutes between off-hours and onhours. This absolute difference in D2B time in our analysis is lower than that reported by Jneid et al 3 (25 minutes) and Magid et al 16 (21.3 minutes) . This may point to the fact that there has been an overall significant reduction in D2B time, regardless of the time of presentation. Short D2B times and early invasive strategies have proven to reduce cardiovascular events in patients presenting with STEMI. Thus, there is an impetus to provide timely care to all patients with STEMI, regardless of the time of presentation. [17] [18] [19] [20] [21] [22] The D2B Alliance, a national quality campaign initiative to achieve timely reperfusion in STEMI; Mission Lifeline; and the Centers for Medicare and Medicaid Services' national Table 3 *Adjusted for variables in the ACTION in-hospital mortality model: initial serum creatinine, age, systolic blood pressure on presentation, initial troponin, heart failure (HF), or shock on admission (HF only, shock only, or HF with shock, vs none), heart rate on presentation, and prior peripheral arterial disease.
. Diagnostic and Reperfusion Strategies of Patients With ST-Segment-Elevation Myocardial Infarction Based on Time of Presentation
†After exclusion of nonsystem reason for delay in PCI (n=4155).
STEMI performance measures have strived to improve quality of care in patients with STEMI. [23] [24] [25] These quality measures may have been associated with a significant decrease in D2B times in patients with STEMI, regardless of the time of presentation. As demonstrated previously, the delay in D2B time offhours is affected primarily by the time delay from diagnosis in the emergency department to catheterization laboratory transfer rather than a delay in initial diagnosis or subsequent catheterization laboratory arrival to balloon inflation. 16 Although our study could not determine the reason for the 16-minute longer D2B times in patients presenting off-hours, we think that the lack of in-house catheterization laboratory personnel at all hospitals during off-hours explains at least some of the difference. Quality improvement initiatives thus should continue to focus on attainment of quality measures and improving awareness of STEMI in the general public and early presentation to reduce symptom onset to door times.
Compared with previous reports, we observed lower in-hospital mortality (4.2% in both groups), regardless of the time of presentation. In-hospital all-cause mortality among patients undergoing primary PCI was 4.1% in both off-hour and onhour groups. Magid et al 16 reported an in-hospital mortality rate of 4.7% (among those undergoing primary PCI), whereas Jneid et al 3 reported a 7.5% mortality rate during both on-hours and off-hours. Although the exact reasons for such an improvement cannot be ascertained, it could be attributed to improvements in reperfusion times during both on-hours and off-hours and aggressive medical management with dual antiplatelet therapies and other class 1 recommended therapies. Compared with previous data, time to reperfusion has improved significantly, and greater proportions of patients with STEMI are now receiving primary PCI and achieving a D2B time of ≤90 minutes. Furthermore, compared with data from Jneid et al, 3 the use of aspirin in the first 24 hours has approached 99% (versus 91%), and the use β-blockers in the first 24 hours has increased to 95% (versus 84%). Although comparative data are unavailable, the use of thienopyridine drugs in the first 24 hours was >90% in our analysis. The increased use of such proven therapies may also have had a favorable impact on in-hospital mortality observed in our study. Our study did show higher mortality in patients presenting off-hours in the overall cohort. However, this risk-adjusted mortality became insignificant when patients with nonsystem reason for delay were excluded from the analysis. Whether this higher mortality stems from the 16-minute delay in D2B time off-hours is debatable and cannot be ascertained based on the current analysis. Further analysis is warranted to shed light on this.
A small proportion (<3%) of patients in our analysis received fibrinolysis. Hospitals that submit data to the ACTION *ACTION-GWTG major bleeding was defined as an absolute hemoglobin (Hgb) drop of ≥4g/dL (initial to nadir), intracranial hemorrhage, documented or suspected retroperitoneal bleed, any red cell blood transfusion with the baseline Hgb ≥9 g/dL, or any red cell transfusion with the Hgb <9 g/dL and a suspected bleeding event.
Registry-GWTG are primary PCI centers. The achievement of D2N time ≤30 minutes was still less than optimal both during on-hours and off-hours, although there was no difference in this quality measure between patients presenting on-hours versus off-hours. This may be because of less-than-perfect processes of care for implementation of fibrinolytic therapy in PCI-equipped hospitals. Concerted effort to optimize the system of care for fibrinolytic administration in PCI-equipped facilities is warranted.
Limitations
Our analysis is unable to determine the long-term impact of our observations of improvements of patient care in on-hour and off-hour patients. Residual measured and unmeasured confounding factors may account for some or all of these findings. More recent heavy emphasis on Centers for Medicare and Medicaid core measures and value-based purchasing has significantly altered the dynamic. We assume that this may have led to continued improvement in the attainment of such quality measures. However, the present analysis is limited to 2007 to 2010. The proportion of patients who received fibrinolytic treatment was substantially low precluding any further analysis in this subgroup. Reporting D2N times in small numbers and from these primary PCI centers may not add much to our understanding of this strategy of STEMI care based on this analysis.
Conclusions
Our data demonstrate that in contemporary community practice achievement of key quality measures in STEMI care (door-to-ECG time ≤10 minutes and aspirin use within 24 hours) was high, regardless of the time of presentation. D2B time was delayed (by an average of 16 minutes), and riskadjusted in-hospital mortality was higher for patients with STEMI presenting off-hours.
